Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Edwards

Showing results (1251-1260 of 1,259) with videos related to

Pageof 126
Sort By:
You have reached the last page of results.This site can display upto 1,259 results.
Carcinogenesis|October 2, 2015
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancerKate Lawrenson, Edwin S Iversen, Jonathan Tyrer, et al.
Plos One|July 7, 2018
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibilityMadalene Earp, Jonathan P Tyrer, Stacey J Winham, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Communications|September 23, 2015
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerKate Lawrenson, Qiyuan Li, Siddhartha Kar, et al.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Genetic Epidemiology|September 25, 2015
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) RiskErnest K Amankwah, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 126

Showing results (1251-1260 of 1,259) with videos related to

Sort By:
Pageof 126
You have reached the last page of results.This site can display upto 1,259 results.
Carcinogenesis|October 2, 2015
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancerKate Lawrenson, Edwin S Iversen, Jonathan Tyrer, et al.
Plos One|July 7, 2018
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibilityMadalene Earp, Jonathan P Tyrer, Stacey J Winham, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Communications|September 23, 2015
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerKate Lawrenson, Qiyuan Li, Siddhartha Kar, et al.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Genetic Epidemiology|September 25, 2015
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) RiskErnest K Amankwah, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 126